These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8922045)

  • 21. On the cardiac adrenergic blocking action of iproveratril in normal and coronary-ligated dogs.
    Melville KI; Garvey HL; Shister HE
    Rev Can Biol; 1968 Sep; 27(3):225-35. PubMed ID: 5702439
    [No Abstract]   [Full Text] [Related]  

  • 22. [Significance of trimetazidine for out of hospital physical rehabilitation after myocardial infarction].
    Aronov DM; Tartakovskiĭ LB; Novikova NK; Pisareva NA; Smolenskiĭ VS; Zhidko NI
    Kardiologiia; 2002; 42(11):14-20. PubMed ID: 12494029
    [No Abstract]   [Full Text] [Related]  

  • 23. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Protective effects of trimetazidine during acute hypoxia].
    Smirnov AV; Krivoruchko BI; Zarubina IV; Mironova OP
    Biull Eksp Biol Med; 1998 Apr; 125(4):410-2. PubMed ID: 9631723
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of trimetazidine on atrial structural remodeling and platelet activation in dogs with atrial fibrillation.
    Han W; Li WM; Zhou HY; Huo H; Wei N; Dong G; Cao Y; Zhou G; Yang SS
    Chin Med J (Engl); 2009 Sep; 122(18):2180-3. PubMed ID: 19781307
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure-activity studies on the protection of Trimetazidine derivatives modified with nitroxides and their precursors from myocardial ischemia-reperfusion injury.
    Kálai T; Khan M; Balog M; Kutala VK; Kuppusamy P; Hideg K
    Bioorg Med Chem; 2006 Aug; 14(16):5510-6. PubMed ID: 16697647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model of ischemia-reperfusion.
    Ruixing Y; Wenwu L; Al-Ghazali R
    Transl Res; 2007 Mar; 149(3):152-60. PubMed ID: 17320801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The electrophysiological effects of disopyramide (author's transl)].
    Ponsonnaille J; Marcheix JC; Gras H
    Ann Cardiol Angeiol (Paris); 1977; 26(2):135-9. PubMed ID: 900834
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of trimetazidine on the brain metabolism during ischemia complicated by hypoxia].
    Smirnov AB; Zarubina IV; Krivoruchko BI; Mironova OP
    Biull Eksp Biol Med; 2000 Feb; 129(2):142-4. PubMed ID: 10732230
    [No Abstract]   [Full Text] [Related]  

  • 30. Trimetazidine in the myocardial cell mechanisms of cytoprotection.
    Labrid C
    Rom J Intern Med; 1998; 36(3-4):137-44. PubMed ID: 10822510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The electrophysiology of Norpace (Part II).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):116-9. PubMed ID: 1115398
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of disopyramide on cardiovascular dynamics in man].
    Aquaro G; Poletti T; Pavia M; D'Arrigo A
    Boll Soc Ital Cardiol; 1971; 16(9):587-90. PubMed ID: 4948542
    [No Abstract]   [Full Text] [Related]  

  • 33. Vasodilator effect of trimetazidine on cutaneous microcirculation of normal conscious rabbits.
    Asano M; Ohkubo C; Sawanobori K
    Jpn J Pharmacol; 1983 Aug; 33(4):891-3. PubMed ID: 6632386
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac mitochondrial alterations induced by insulin deficiency and hyperinsulinaemia in rats: targeting membrane homeostasis with trimetazidine.
    Ovide-Bordeaux S; Bescond-Jacquet A; Grynberg A
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1061-70. PubMed ID: 16445572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The electrophysiology of Norpace (Part III).
    Caracta A
    Angiology; 1975 Jan; 26(1 Pt 2):120-3. PubMed ID: 1115399
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of chronic trimetazidine treatment on myocardial preconditioning in anesthetized rats.
    Kara AF; Demiryürek S; Celik A; Tarakçioğlu M; Demiryürek AT
    Fundam Clin Pharmacol; 2006 Oct; 20(5):449-59. PubMed ID: 16968415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of disopyramide in comparison with verapamil and propranolol in the prevention of acetylcholine-induced atrial fibrillation in the dog.
    Bertrix L; Timour Chah Q; Lang J; Lakhal M; Bouzouita K; Faucon G
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):97-110. PubMed ID: 4015264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of epicardial QT intervals in the assessment of ventricular repolarisation dispersion.
    Wang L
    Gen Physiol Biophys; 2003 Jun; 22(2):213-20. PubMed ID: 14661733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy].
    Sisakian AS; Torgomian AL; Barkhudarian AL
    Klin Med (Mosk); 2006; 84(10):55-8. PubMed ID: 17201276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.